Indications for implantable automatic ventricular defibrillators. A report from the Heart Rhythm Group of the French Society of Cardiology
Aliot, E.; Chauvin, M.; Daubert, J.C.; Frank, R.; Jondeau, G.; Leclercq, J.F.; Le Heuzey, J.Y.
Archives des maladies du coeur et des vaisseaux 99(2): 141-154
2006
ISSN/ISBN: 0003-9683 PMID: 16555698 Document Number: 601899
Document emailed within 1 workday
Related Documents
Thomas, O.; Extramiana, F.; Milliez, P.; Cauchemez, B.; Coumel, P.; Leenhardt, A. 2003: Indications for implantable automatic defibrillators: critical analysis Archives des Maladies du Coeur et des Vaisseaux 96(Special Issue 4): 54-61Gibelin, P.; Aumont, M.C.; Aupetit, J.F.; Bareiss, P.; Bouhour, J.B.; Desnos, M.; Dubourg, O.; Hagège, A.; Jondeau, G.; Komajda, M. 1999: Evaluation of a specific French scale of activity in chronic heart failure. A national multicenter study. Group for Cardiac Insufficiency and Cardiomyopathy of the French Society of Cardiology Archives des Maladies du Coeur et des Vaisseaux 92(9): 1175-1180
Sandoe, J.A.T.; Barlow, G.; Chambers, J.B.; Gammage, M.; Guleri, A.; Howard, P.; Olson, E.; Perry, J.D.; Prendergast, B.D.; Spry, M.J.; Steeds, R.P.; Tayebjee, M.H.; Watkin, R. 2015: Guidelines for the diagnosis, prevention and management of implantable cardiac electronic device infection. Report of a joint Working Party project on behalf of the British Society for Antimicrobial Chemotherapy (BSAC, host organization), British Heart Rhythm Society (BHRS), British Cardiovascular Society (BCS), British Heart Valve Society (BHVS) and British Society for Echocardiography (BSE) Journal of antimicrobial chemotherapy 70(2): 325-359
Bodar', V.I.; Razymovskii, V.A.; Belokon', N.S. 1996: Automatic implantable cardioverter-defibrillators in treating life-threatening ventricular tachyarrhythmias Klinicheskaia Meditsina 74(7): 58-59
Gioia, G.; Bagheri, B.; Gottlieb, C.D.; Schwartzman, D.S.; Callans, D.J.; Marchlinski, F.E.; Heo, J.; Iskandrian, A.E. 1997: Prediction of outcome of patients with life-threatening ventricular arrhythmias treated with automatic implantable cardioverter-defibrillators using SPECT perfusion imaging Circulation 95(2): 390-394
Occhetta, E. 2000: The benefits of the implantable cardioverter-defibrillator in comparisons with anti-arrhythmia agents in patients surviving malignant ventricular tachyarrhythmias: a subanalysis of the AVID study by varying degrees of left ventricular dysfunction. Antiarrhythmic versus Implantable Defibrillators Italian Heart Journal. Suppl: Official Journal of the Italian Federation of Cardiology 1(4): 577-578
Joffre, F.; Daubert, J.C. 2006: Consensus recommendations from the French Society of Radiology and French Society of Cardiology for appropriate management of patients requiring CT or MRI Journal de Radiologie 87(1): 76
Leenhardt, A.; Thomas, O.; Bel, A.; Bizot, J.; Coumel, P.; Slama, R. 1994: Automatic implantable defibrillators: long-term results Archives des Maladies du Coeur et des Vaisseaux 87(11 Suppl): 1617-1622
Fabián, J.; Bytesník, J.; Náprstek, Z. 1986: Treatment of life-threatening tachyarrhythmias using implantable automatic defibrillators Vnitrni Lekarstvi 32(4): 398-405
Delaye, J. 1980: The risk of coronary angiography in unstable angina. Survey by the working group of "Functional cardiovascular tests" of the French Society of Cardiology Archives des Maladies du Coeur et des Vaisseaux 73(2): 211-215
Von Bibra, H.; Fehske, W. 1999: Reports of the German Society of Cardiology-Heart and Cardiovascular Research. Report of activities of the Cardiovascular Ultrasound Study Group 1998/99 Zeitschrift für Kardiologie 88(10): 880-882
Stack, J.M.; Houston, C.; Mirowski, M.; Mower, M.; Watkins, L.; Reid, P.R. 1982: Automatic implantable defibrillator for the patient with recurrent refractory malignant ventricular arrhythmias: case report Heart and Lung: the Journal of Critical Care 11(6): 512-515
Gohlke-Bärwolf, C.; Acar, J.; Oakley, C.; Butchart, E.; Burckhart, D.; Bodnar, E.; Hall, R.; Delahaye, J.P.; Horstkotte, D.; Krémer, R. 1995: Guidelines for prevention of thromboembolic events in valvular heart disease. Study Group of the Working Group on Valvular Heart Disease of the European Society of Cardiology European Heart Journal 16(10): 1320-1330
Gohlke, H.; Kübler, W.; Mathes, P.; Meinertz, T.; Schuler, G.; Gysan, D.B.; Sauer, G. 2001: Recommendations for an extensive risk decrease for patients with coronary disease, vascular diseases and diabetes. Issued by the Executive Committee of the German Society of Cardiology, Heart and Circulation Research, reviewed on behalf of the Clinical Cardiology Commission by the Prevention Project Group Zeitschrift für Kardiologie 90(2): 148-149
Przybylski, A. 2009: Interruption of slow ventricular tachycardia below the detection rate of implantable cardioverter-defibrillators Kardiologia Polska 67(11): 1296
Rothlin, M. 1995: Heart interventions in Switzerland 1992. PTCA and Fibrinolysis Study Group of the Swiss Society of Cardiology Schweizerische Medizinische Wochenschrift 125(4): 136
Fleck, E.; von Lutterotti, N. 1999: Reports by the German Society of Cardiology--Heart- and Cardiovascular Research. Clinical Epidemiology Working Group Zeitschrift für Kardiologie 88(9): 687-692
Mühlberger, V.; Klein, W.; Mlczoch, J.; Probst, P. 1996: Quality assurance in invasive and interventional cardiology in Austria in 1994. Commissioned by the Interventional Cardiology Working Group of the Austrian Cardiology Society Zeitschrift für Kardiologie 85(9): 647-655
Wietholt, D.; Block, M.; Isbruch, F.; Böcker, D.; Hammel, D.; Borggrefe, M.; Scheld, H.H.; Breithardt, G. 1993: Therapy of ventricular tachyarrhythmia with implantable cardioverters/defibrillators--mortality and complications using epicardial electrodes Zeitschrift für Kardiologie 82(3): 150-161
Uretsky, B.F. 1997: Implantable defibrillators in patients with coronary artery disease at high risk for ventricular arrhythmia New England Journal of Medicine 336(23): 1677